From: Unraveling the therapeutic effects of mesenchymal stem cells in asthma
Status | Study title | Conditions | Interventions | Phase | Number enrolled |
---|---|---|---|---|---|
Active, not recruiting | Allogeneic human cells (hMSCs) via intravenous delivery in patients With Mild asthma | Asthma | Biological: hMSCs | 1 | 6 |
Active, not recruiting | Safety and feasibility study of an intranasal mesenchymal trophic factor for the treatment of asthma | Asthma | Biological: trophic factors from umbilical cord mesenchymal stem cells | 1 and 2 | 20 |
Completed | Study to evaluate the effect of benralizumab on allergen-induced inflammation in mild, atopic asthmatics | Asthma | Biological: benralizumab, other: placebo | Phase 3 | 46 |
Completed | A pilot study for cell-based therapies in patients with asthma | Asthma, allergic rhinitis | Other: blood donation | Not applicable | 20 |